Patents by Inventor Karl F. Popp

Karl F. Popp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150119827
    Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
    Type: Application
    Filed: January 9, 2015
    Publication date: April 30, 2015
    Inventors: Keith A. Johnson, Karl F. Popp
  • Patent number: 8962028
    Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: February 24, 2015
    Assignee: MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company
    Inventors: Keith A. Johnson, Karl F. Popp
  • Publication number: 20140112959
    Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
    Type: Application
    Filed: June 19, 2013
    Publication date: April 24, 2014
    Applicant: MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite
    Inventors: Keith A. Johnson, Karl F. Popp
  • Publication number: 20140112991
    Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
    Type: Application
    Filed: June 19, 2013
    Publication date: April 24, 2014
    Applicant: MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division LLC
    Inventors: Keith A. Johnson, Karl F. Popp
  • Patent number: 7829107
    Abstract: Novel compositions of matter comprising a foamable delivery system are provided. Novel methods for treating a disease, disorder, or condition using the novel compositions are further provided. Novel methods for making and delivering a foamable pharmaceutical composition are also provided. While the novel compositions and foamable drug delivery system may be utilized for administration of a wide variety of drugs to epithelial tissues, to treat a wide variety of diseases, disorders, or conditions, the inventive compositions and foamable drug delivery systems are particularly useful for the dermatological administration of corticosteroids and antifungal agents.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: November 9, 2010
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Karl F. Popp, Edward R. Yuhas
  • Publication number: 20100210571
    Abstract: Topical compositions and methods of using same for treating skin disorders or conditions comprising a storage-stable mixture of a benzoyl peroxide dispersion, clindamycin or pharmaceutically acceptable salts or esters thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 30, 2010
    Publication date: August 19, 2010
    Applicant: STIEFEL LABORATORIES, INC.
    Inventor: Karl F. Popp
  • Publication number: 20080287373
    Abstract: A kit comprising a soap-free cleanser and a topical composition which comprises clindamycin or a pharmaceutically acceptable salt or ester thereof, and a pharmaceutically acceptable carrier, formulations and packages thereof, and methods of using the same to treat various skin disorders.
    Type: Application
    Filed: May 17, 2007
    Publication date: November 20, 2008
    Inventor: Karl F. Popp
  • Publication number: 20080026039
    Abstract: Pharmaceutical delivery systems suitable for topical administration including benzoyl peroxide. In a particular aspect, these pharmaceutical delivery systems comprise at least one pad and a drug composition comprising benzoyl peroxide absorbed onto the pad. These compositions are used for topical medical applications, particularly to treat various skin disorders.
    Type: Application
    Filed: July 26, 2006
    Publication date: January 31, 2008
    Applicant: STIEFEL LABORATORIES, INC.
    Inventor: Karl F. Popp
  • Patent number: 7186416
    Abstract: Novel compositions of matter comprising a foamable delivery system are provided. Novel methods for treating a disease, disorder, or condition using the novel compositions are further provided. Novel methods for making and delivering a foamable pharmaceutical composition are also provided. While the novel compositions and foamable drug delivery system may be utilized for administration of a wide variety of drugs to epithelial tissues, to treat a wide variety of diseases, disorders, or conditions, the inventive compositions and foamable drug delivery systems are particularly useful for the dermatological administration of corticosteroids and antifungal agents.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: March 6, 2007
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Karl F. Popp, Edward R. Yuhas
  • Publication number: 20040241099
    Abstract: Novel compositions of matter comprising a foamable delivery system are provided. Novel methods for treating a disease, disorder, or condition using the novel compositions are further provided. Novel methods for making and delivering a foamable pharmaceutical composition are also provided. While the novel compositions and foamable drug delivery system may be utilized for administration of a wide variety of drugs to epithelial tissues, to treat a wide variety of diseases, disorders, or conditions, the inventive compositions and foamable drug delivery systems are particularly useful for the dermatological administration of corticosteroids and antifungal agents.
    Type: Application
    Filed: May 28, 2003
    Publication date: December 2, 2004
    Inventors: Karl F. Popp, Edward R. Yuhas
  • Publication number: 20040185016
    Abstract: A composition for treatment of hyperpigmentation having a SPF value of at least 15 includes hydroquinone, sunscreens, antioxidants and emulsifiers and emollients. The composition can be made into an emulsion having physical and chemical stability for a prolonged period of time over a wide range of temperatures.
    Type: Application
    Filed: March 1, 2004
    Publication date: September 23, 2004
    Inventors: Karl F. Popp, Kathleen L. Clark
  • Publication number: 20040171561
    Abstract: Methods of using a topical composition comprising a storage-stable mixture of a benzoyl peroxide dispersion and clindamycin or pharmaceutically acceptable salts or esters thereof for treating rosacea. These methods also contemplate the reduction or elimination of Demodex folliculorum organisms from affected skin areas, thereby reducing clinical signs of rosacea potentially due to allergic and vasomotor responses of the body to the organism in susceptible persons.
    Type: Application
    Filed: March 4, 2004
    Publication date: September 2, 2004
    Inventor: Karl F. Popp
  • Publication number: 20040167223
    Abstract: Methods of using a topical composition comprising a storage-stable mixture of a benzoyl peroxide dispersion and clindamycin or pharmaceutically acceptable salts or esters thereof for treating a bacterial disorder. These methods also contemplate the reduction or elimination of particular bacteria from affected skin areas, thereby reducing skin lesions or infections.
    Type: Application
    Filed: February 27, 2004
    Publication date: August 26, 2004
    Inventor: Karl F. Popp
  • Publication number: 20040043946
    Abstract: Topical compositions and methods of using same for treating skin disorders or conditions comprising a storage-stable mixture of a benzoyl peroxide dispersion, clindamycin or pharmaceutically acceptable salts or esters thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: July 11, 2003
    Publication date: March 4, 2004
    Inventor: Karl F. Popp
  • Patent number: 6699464
    Abstract: A composition for treatment of hyperpigmentation having a SPF value of at least 15 includes hydroquinone, sunscreens, antioxidants and emulsifiers and emollients. The composition can be made into an emulsion having physical and chemical stability for a prolonged period of time over a wide range of temperatures.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: March 2, 2004
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Karl F. Popp, Kathleen L. Clark
  • Patent number: 6630158
    Abstract: A dietary supplement composition for promoting healthy skin comprised of lycopene and other carotenoids, selenium, chromium and biotin.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: October 7, 2003
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Karl F. Popp, Samuel J. Alioto
  • Publication number: 20020192272
    Abstract: A dermatological delivery system comprising a topically acceptable, inert support selected from the group consisting of cotton, rayon, polyester, polypropylene, wood pulp, mohair, nylon fleece, and neoprene foam, or combination thereof, impregnated with an about 0.1% to about 2% solution of metronidazole; the solution having a major solvent component comprising water, ethanol or a mixture of water and ethanol, the support being operable to permit application of the solution to the skin.
    Type: Application
    Filed: January 10, 2002
    Publication date: December 19, 2002
    Inventor: Karl F. Popp
  • Publication number: 20020132800
    Abstract: A dietary supplement composition for promoting healthy skin comprised of lycopene and other carotenoids, selenium, chromium and biotin.
    Type: Application
    Filed: October 30, 2001
    Publication date: September 19, 2002
    Inventors: Karl F. Popp, Samuel J. Alioto
  • Patent number: 6433024
    Abstract: The present invention is directed towards a topical composition for the treatment of acne comprising water, an organic peroxide, an alpha hydroxy acid, a moisturizer, an isosorbide and a detergent. This invention also is directed to a method of making the composition of this invention. The method involves (1) heating water to between 60° C. and 70° C.; (2) adding a detergent base to the water and mixing the solution; (3) cooling the solution and adding an alpha hydroxy acid, an isosorbide and sodium pyrollidone carboxylate; (4) continuing to cool the solution to between 25° C. and 35° C. and then adding benzoyl peroxide and a preservative to the solution; (5) mixing and milling the product until smooth; and (6) adjusting the pH of the product to a pH of 3-5 with a base. This invention also is directed towards a method for treating a patient afflicted with acne by applying the composition of this invention to the affected areas of the patient's skin.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: August 13, 2002
    Inventors: Karl F. Popp, Brent D. Stiefel
  • Patent number: 5525358
    Abstract: Gel film-forming flexible collodion compositions can be improved by including one or more topically acceptable polymers in an amount sufficient to increase the resilience of the film formed. Suitable polymers include polyalkylenes and (meth)acrylate homo- or copolymers. The compositions can further include salicylic acid and a topically acceptable crystallization inhibitor in an amount sufficient to suppress the crystallization of dissolved salicylic acid from the composition.
    Type: Grant
    Filed: April 19, 1995
    Date of Patent: June 11, 1996
    Assignee: Schering-Plough Healthcare Products, Inc.
    Inventor: Karl F. Popp